Showing 101 - 120 results of 284 for search '"platinum"', query time: 0.06s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104

    Efficacy and safety of perioperative sintilimab plus platinum-based chemotherapy for potentially resectable stage IIIB non-small cell lung cancer (periSCOPE): an open-label, single-arm, phase II trialResearch in context by Xiangyang Yu, Chujian Huang, Longde Du, Chunguang Wang, Yikun Yang, Xin Yu, Shengcheng Lin, Chenglin Yang, Hongbo Zhao, Songhua Cai, Zhe Wang, Lixu Wang, Xiaotong Guo, Baihua Zhang, Zhentao Yu, Jie He, Kai Ma

    Published 2025-01-01
    “…We designed this trial to explore the efficacy and safety of perioperative sintilimab plus platinum-based chemotherapy for potentially resectable stage IIIB NSCLC to facilitate further optimization of this therapeutic strategy. …”
    Get full text
    Article
  5. 105

    Communicating with diversities by Tanya le Roux, Annelie Naudé

    Published 2022-10-01
    Subjects: “…South African platinum-mining industry…”
    Get full text
    Article
  6. 106
  7. 107

    Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE) by Hidekazu Hirano, Naoki Takahashi, Yusuke Amanuma, Nobumi Suzuki, Daisuke Takahari, Takeshi Kawakami, Chie Kudo-Saito, Kengo Nagashima, Narikazu Boku, Ken Kato, Hirokazu Shoji

    Published 2025-02-01
    “…Key eligibility criteria are as follows: (1) advanced gastric or esophagogastric junction cancer, (2) histologically confirmed diagnosis of adenocarcinoma, (3) refractory to first-line treatment including fluoropyrimidines, platinum, and an anti-PD-1/PD-L1 antibody, (4) performance status of 0–1, and (5) at least one measurable lesion. …”
    Get full text
    Article
  8. 108
  9. 109

    mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin by Kewei Zheng, Yi Gao, Jing Xu, Mingyi Kang, Ranran Chai, Guanqin Jin, Yu Kang

    Published 2024-12-01
    “…Current chemotherapy regimens are predominantly platinum-based; however, the development of platinum resistance during treatment significantly worsens patient outcomes. …”
    Get full text
    Article
  10. 110

    INVESTIGATION OF RATIONAL BUBBLES AND VOLATILITY SPILLOVERS IN COMMODITY MARKETS: EVIDENCES FROM PRECIOUS METALS by İsmail Çelik, Hilmi Tunahan Akkuş, Nazlıgül Gülcan

    Published 2019-12-01
    “…As a resultof the analysis, price bubbles were found in gold, silver and platinum, whereasno bubbles were found in palladium prices. …”
    Get full text
    Article
  11. 111

    Gas-sensitive properties of por-SiO2 /SnOx multilayer structures by E. A. Roslikova, V. E. Roslikov, K. E. Ivlev

    Published 2018-07-01
    “…The EDA data shows the existence of platinum in the nanocomposite. Investigation of gas sensitive properties shows that the obtained test structures with platinum have a higher sensitivity to CO and CH4 gas molecules at a temperature of 150 °C than structures with tin oxide without platinum.…”
    Get full text
    Article
  12. 112

    The Design and Construction of a Bolometer. by Twizerimana, Julliet

    Published 2023
    “…This project on the design and construction of a bolometer is conducted in October 2020 at Kabale University in Kabale district, Southwestern Uganda. A blackened platinum strip of a zigzag form as the heat sensitive element will be connected in a Wheatstone bridge with different resistors and a galvanometer will be used for the study aimed at investigating the effect of thermal /heat radiation on the resistance of the platinum strip or the bolometer. …”
    Get full text
    Other
  13. 113

    Photooxidation of Toluene: Correlation of Noble Metal Loading on Titania and Activation Energy by Haroon ur Rashid, Mohammad Sadiq, Muhammad Abid Zia, Saima Sadiq, M. Sohail Ahmad, Razia Aman, Muhammad Humayun, Rahmat Ali

    Published 2016-01-01
    “…A series of platinum and palladium supported on titania catalysts were prepared by wet impregnation method with the Pt or Pd loading varying in the range of 0.1–1.2 weight percent. …”
    Get full text
    Article
  14. 114
  15. 115

    Synergy of the Combination of Titanate Nanotubes with Titania Nanoparticles for the Photocatalytic Hydrogen Generation from Water-Methanol Mixture Using Simulated Sunlight by Marco Serra, Hermenegildo Garcia

    Published 2014-01-01
    “…This synergy between the two titanium semiconductors has an optimum for a certain proportion of the two components and is observed in both the absence and the presence of platinum or gold nanoparticles. The best efficiency under simulated sunlight irradiation was for a combination of 12 wt.% titanate nanotubes containing 0.32 wt.% platinum in 88 wt.% Millennium PC500, where a two-time increase in the hydrogen generation is observed versus the activity of Millennium PC500 containing platinum. …”
    Get full text
    Article
  16. 116

    Separating nanobubble nucleation for transfer-resistance-free electrocatalysis by Shasha Guo, Maolin Yu, Jinn-Kye Lee, Mengyi Qiu, Dundong Yuan, Zhili Hu, Chao Zhu, Yao Wu, Zude Shi, Wei Ma, Shuangyin Wang, Yongmin He, Zhengyang Zhang, Zhuhua Zhang, Zheng Liu

    Published 2025-01-01
    “…Herein, we develop an on-chip microcell-based total-internal-reflection-fluorescence-microscopy to enable operando imaging of bubbles at sub-50 nm and dynamic probing of their nucleation during hydrogen evolution reaction. Using platinum-interfacial metal layer-graphene as model systems, we demonstrate that the strong binding energy between interfacial metal layer and graphene—evidenced by a reduced metal-support distance and enhanced charge transfer—facilitates hydrogen spillover from platinum to the graphene support due to lower energy barriers compared to the platinum-graphene system. …”
    Get full text
    Article
  17. 117

    Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer by Ekamjit S. Deol, Reza Nabavizadeh, Roxane R. Lavoie, Mihai G. Dumbrava, Edlira Horjeti, Prabin Thapa, John C. Cheville, Igor Frank, Fabrice Lucien

    Published 2024-11-01
    “…Abstract Background Neoadjuvant platinum‐based chemotherapy offers a modest survival advantage in muscle‐invasive bladder cancer (MIBC) for patients with pathologic response. …”
    Get full text
    Article
  18. 118

    Update on the Treatment of Metastatic Urothelial Carcinoma by Nedal Bukhari, Humaid O. Al-Shamsi, Faisal Azam

    Published 2018-01-01
    “…Platinum-based combination chemotherapy has been the standard of care in the first-line treatment of metastatic urothelial carcinoma (mUC). …”
    Get full text
    Article
  19. 119

    Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model by Fumihiro Yamane, Kenji Ikemura, Masayoshi Kondo, Manami Ueno, Masahiro Okuda

    Published 2025-01-01
    “…Because hOCT2 is responsible for the development of adverse effects caused by platinum-based anti-cancer agents, drugs with OCT2 inhibitory effects may serve as prophylactic agents against the toxicity of platinum-based anti-cancer agents. …”
    Get full text
    Article
  20. 120

    Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers by Zhihao Lu, Mingfei Geng, Yongtao Han, Jianzhong Cao, Jun Wang, Tianshu Liu, Xianglin Yuan, Xue Meng, Yanqiao Zhang, Rong Zhao, Lixin Wan, Enxiao Li, Wenran Wang, Zhijie Li, Danfeng Shi, Jing Qian, Si Shi, Fengshi Dong, Lin Shen

    Published 2024-12-01
    “…Among patients with resectable EC, 92.9% received initial surgery, and 7.1% received neoadjuvant therapy, primarily chemotherapy (85.5% platinum-taxane). Among patients with unresectable early or locally advanced EC, 50.8% and 49.2% received palliative and radical therapy, respectively, as the initial treatment, primarily chemotherapy (66.5% platinum-taxane) and chemoradiotherapy (50.8% platinum-taxane), respectively. …”
    Get full text
    Article